Search Results - "WYNN, D. R"

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis by BALCER, L. J, GALETTA, S. L, O'CONNOR, P. W, PHILLIPS, J. T, POLMAN, C. H, RADUE, E.-W, RUDICK, R. A, STUART, W. H, WAJGT, A, WEINSTOCK-GUTTMAN, B, WYNN, D. R, LYNN, F, CALABRESI, P. A, PANZARA, M. A, CONFAVREUX, C, GIOVANNONI, G, HAVRDOVA, E, HUTCHINSON, M, KAPPOS, L, LUBLIN, F. D, MILLER, D. H

“…To examine the effects of natalizumab on low-contrast letter acuity as a prespecified tertiary endpoint in two randomized clinical trials and to evaluate the…”
Get full text

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL by Hutchinson, M., Kappos, L., Calabresi, P. A., Confavreux, C., Giovannoni, G., Galetta, S. L., Havrdova, E., Lublin, F. D., Miller, D. H., O’Connor, P. W., Phillips, J. T., Polman, C. H., Radue, E.-W., Rudick, R. A., Stuart, W. H., Wajgt, A., Weinstock-Guttman, B., Wynn, D. R., Lynn, F., Panzara, M. A.

“…The AFFIRM and SENTINEL studies showed that natalizumab was effective both as monotherapy and in combination with interferon beta (IFNβ)-1a in patients with…”
Get full text

A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota by WYNN, D. R, RODRIGUEZ, M, O'FALLON, W. M, KURLAND, L. T

“…A review of multiple sclerosis (MS) case reports, using the unified record system at the Mayo Clinic for the Olmsted County population, revealed age- and…”
Get full text

The scientific basis of migraine by Wynn, D R

“…Through genetic studies and neuroimaging techniques, our knowledge of the scientific basis of migraine continues to grow. The assumption that migraine is an…”
Get full text

Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls by RODRIGUEZ, M, WYNN, D. R, KIMLINGER, T. K, KATZMANN, J. A

“…We measured the concentration of C9 in the CSF and plasma of 93 consecutive patients referred for CSF examination in an outpatient multispecialty clinic. We…”
Get full text

Weaning of free-ranging infant baboons (Papio cynocephalus) as indicated by one-zero and instantaneous sampling of feeding by RHINE, R. J, NORTON, G. W, WYNN, G. M, WYNN, R. D

“…Weaning from the nipple and the use of solid foods were studied by one-zero and instantaneous sampling during the first year of life for 46 baboon infants. By…”
Get full text

Plant feeding of yellow baboons (Papio cynocephalus) in Mikumi National Park, Tanzania, and the relationship between seasonal feeding and immature survival by RHINE, R. J, NORTON, G. W, WYNN, G. M, WYNN, R. D

“…Focal-animal feeding data obtained from 64 adult baboons during a 3-year period were used together with equivalent data from 46 infants to evaluate hypotheses…”
Get full text

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis by Rudick, Richard A, Stuart, William H, Calabresi, Peter A, Confavreux, Christian, Galetta, Steven L, Radue, Ernst-Wilhelm, Lublin, Fred D, Weinstock-Guttman, Bianca, Wynn, Daniel R, Lynn, Frances, Panzara, Michael A, Sandrock, Alfred W

“…In this randomized trial involving patients with relapsing multiple sclerosis who had had relapses despite treatment with interferon, natalizumab in…”
Get full text

The incidence and significance of anti-natalizumab antibodies : Results from AFFIRM and SENTINEL by CALABRESI, P. A, GIOVANNONI, G, POLMAN, C. H, RADUE, E.-W, RUDICK, R. A, STUART, W. H, LUBLIN, F. D, WAJGT, A, WEINSTOCK-GUTTMAN, B, WYNN, D. R, LYNN, F, PANZARA, M. A, CONFAVREUX, C, GALETTA, S. L, HAVRDOVA, E, HUTCHINSON, M, KAPPOS, L, MILLER, D. H, O'CONNOR, P. W, PHILLIPS, J. T

“…To determine the incidence and clinical effects of antibodies that develop during treatment with natalizumab. In two randomized, double-blind,…”
Get full text

Update on the epidemiology of multiple sclerosis by Wynn, D R, Rodriguez, M, O'Fallon, W M, Kurland, L T

“…Neuroepidemiology has been important in providing clues about the cause and pathogenesis of multiple sclerosis. In this review, we update the incidence and…”
Get more information

Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials by Goodman, Andrew D, Bethoux, Francois, Brown, Theodore R, Schapiro, Randall T, Cohen, Ron, Marinucci, Lawrence N, Henney, Herbert R, Blight, Andrew R, Agius, M, Arnason, BGW, Bethoux, FA, Bever, CT, Bowen, JD, Brown, TR, Dietrich, DW, Edwards, K, Freedman, MS, Freedman, M, Kachuck, NJ, Kaufman, MD, Keilson, M, Khan, O, Krupp, LB, Leist, TP, Lindsey, JW, Lublin, FD, Mass, MK, Mattson, D, McGowan, D, Naismith, R, O’Connell, C, Oger, JJ, Panitch, H, Picone, MA, Rammohan, KW, Schapiro, RT, Schwid, SR, Scott, T, Short, C, Thrower, BW, Vollmer, TL, Camac, A, Cooper, JA, Chumley, WF, Cross, A, Dunnigan, RT, Gitt, JS, Hillen, M, Jeffrey, DR, Khatri, BO, Kresa-Reahl, K, Moon, S, Preiningerova, J, Tullman, M, Weinstock-Guttman, B, Wynn, DR

“…Background: In Phase 3 double-blind trials (MS-F203 and MS-F204), dalfampridine extended release tablets 10 mg twice daily (dalfampridine-ER; prolonged-release…”
Get full text

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis by Panitch, Hillel S., Thisted, Ronald A., Smith, Richard A., Wynn, Daniel R., Wymer, James P., Achiron, Anat, Vollmer, Timothy L., Mandler, Raul N., Dietrich, Dennis W., Fletcher, Malcolm, Pope, Laura E., Berg, James E., Miller, Ariel

“…Objective To evaluate the efficacy and safety of DM/Q (capsules containing dextromethorphan [DM] and quinidine [Q]) compared with placebo, taken twice daily,…”
Get full text

A physical sign of bulimia by Wynn, D R, Martin, M J

Get more information

Insect and meat eating among infant and adult baboons (Papio cynocephalus) of Mikumi National Park, Tanzania by Rhine, R J, Norton, G W, Wynn, G M, Wynn, R D, Rhine, H B

“…It has been suggested that baboon predation upon vertebrates may tend to peak in the dry season because insect food is then less available, and that males…”
Get more information

Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes by Coles, Alasdair J, MD, Fox, Edward, MD, Vladic, Anton, MD, Gazda, Suzanne K, MD, Brinar, Vesna, MD, Selmaj, Krzysztof W, MD, Bass, Ann Doan-Do, DO, Wynn, Daniel R, MD, Margolin, David H, MD, Lake, Stephen L, ScD, Moran, Susan, MD, Palmer, Jeffrey, MS, Smith, M Shelton, PhD, Compston, D Alastair S, MD

“…Summary Background Alemtuzumab is a humanised monoclonal antibody that depletes lymphocytes, causing long-term immunomodulation. In a 3-year, rater-blinded…”
Get full text

Epidemiology of MS by Rodriguez, Moses, O'Fallon, Michael, Kurland, Leonard T., Wynn, Daniel R.

Get full text

Baboon diet: a five-year study of stability and variability in the plant feeding and habitat of the yellow baboons (Papio cynocephalus) of Mikumi National Park, Tanzania by Norton, G W, Rhine, R J, Wynn, G W, Wynn, R D

“…The habitat and plant feeding of 64 well-habituated, individually identified adult male and female yellow baboons was studied for 5 years at Mikumi National…”
Get more information

Multiple Sclerosis: A Population-based Investigation of the Association with Neoplastic Disorders: 4:00 PM: 11 by Wynn, D. R., Codd, M. B., Kurland, L. T., Rodriguez, M.

Get full text

Materials Science Teaching Module as Adjunct to Introductory Chemistry by Gulden, Terry D, Norton, Kirk P, Streckert, Holger H, Woolf, Lawrence D, Baron, Joseph A, Brammer, Shauna C, Ezell, Danine L, Wynn, Roger D

“…A materials science teaching module was developed by a team of scientists and teachers that incorporates aspects of chemistry, physics, materials, and…”
Get full text

Staff Utilization, Development, and Evaluation by Wynn, D. Richard, De Remer, Richard W.

Get full text